Medtech venture capitalist Maria Berkman discussed the limited number of venture funds that focus exclusively on medtech, estimating there are less than 100 such funds. She shared insights at the Heart Rhythm Society’s HRX conference, highlighting the dedication of medtech investors who are patient with their time and capital. Berkman emphasized the importance of clinical wins in addition to financial wins in the medtech investment space. She also noted the differences between medtech and tech investors, highlighting the longer timelines for success in the medtech industry. Overall, she stressed the need for patience and measured risk-taking in the medtech investment ecosystem.
Source link
3 Things to Know About Medtech Investment, From a VC
